Luc Mathis
Director Ejecutivo en Meiogenix SAS .
Origen de la red de primer grado Luc Mathis.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Meiogenix SAS
Meiogenix SAS BiotechnologyHealth Technology Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France.
6
| Holding Company | Biotechnology | 6 |
Public Company | Pharmaceuticals: Major | 6 | |
MicroPEP Technologies SAS
MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Public Company | Chemicals: Specialty | 4 | |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.
2
| Extinct | Miscellaneous Commercial Services | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Luc Mathis a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
THE TORO COMPANY | Trucks/Construction/Farm Machinery | Sales & Marketing | |
IRDI Capital Investissement SAS
IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Investment Managers | Private Equity Investor | |
Sud Ouest Capital Risque Innovation SAS
Sud Ouest Capital Risque Innovation SAS Investment ManagersFinance Sud Ouest Capital Risque Innovation SAS invests in innovative companies established in the Aquitaine and Midi-Pyrénées regions. The fund invests in the range of €150,000 - €1 million per transaction and also makes co-investments. | Investment Managers | Chairman | |
Solina France SAS
Solina France SAS Food: Major DiversifiedConsumer Non-Durables Solina France SASU engages in the manufacture of food ingredients. Its products are focused on ready meals; seafood preparations; snacks; salads and vegetables; pizzas, quiches, and pies; sauces; soups; dairy products; organic solutions; marinades; and fresh and cooked products. The company was founded by Eric Terré in 1988 and is headquartered in Bréal-Sous-Monfort, France. | Food: Major Diversified | Chief Executive Officer | |
McGill University | College/University | Masters Business Admin | |
University of Montréal | College/University | Graduate Degree | |
PALUMED SA
PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Director/Board Member | |
TELECOM DESIGN | Specialty Telecommunications | Director/Board Member | |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
ARCADIA BIOSCIENCES, INC. | Chemicals: Agricultural | Founder | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree | |
IXO Private Equity SAS
IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investment Managers | Private Equity Investor | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
Institut National Agronomique Paris-Grignon | College/University | Graduate Degree | |
T-Square, Inc.
T-Square, Inc. Wholesale DistributorsDistribution Services Part of Synaptics, Inc., T-Square, Inc. is a company that wholesales chemicals and allied products. The company is based in Charlotte, NC. The company was founded by Alain Henri Roger Fanet. | Wholesale Distributors | Founder | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Kurma Biofund FCPR
Kurma Biofund FCPR Investment ManagersFinance Kurma Biofund seeks investment opportunities in life science and biotechnology companies located in Europe. The investments are done in cooperation with medical institutes and universities such as Institut Pasteur and Institut Curie. Its investment size ranges between €0.10 and €6 million. | Investment Managers | Corporate Officer/Principal | |
ADVICENNE | Pharmaceuticals: Generic | Director/Board Member | |
Holding Solina SA
Holding Solina SA Food: Major DiversifiedConsumer Non-Durables Holding Solina SA provides ingredient-based functional and culinary solutions for the food industry. The firm offers DENA, formidabel, Saveur, nutrinal and PYC brands. It offers culinary and aromatic solutions, such as stocks, culinary extracts and aromas, sauce bases, sauces, cheese preparations, marinades, seasonings, batters, coatings and spice compositions. The company was founded by Eric M. Terré in 2012 and is headquartered in Breal-Sous-Montfort, France. | Food: Major Diversified | Chief Executive Officer | |
SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member Director of Finance/CFO | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member | |
École Nationale Supérieure de Chimie de Paris | College/University | Undergraduate Degree | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
NEOMA Business School | College/University | Masters Business Admin | |
ffly4u SAS
ffly4u SAS Specialty TelecommunicationsCommunications Ffly4u SASU provides a low frequency localization services for mobile assets. It also offers services like movement, temperature, noise or opening detection in order to guarantee the integrity of sensitive assets. The company was founded by Pages Olivier in 2015 and is headquartered in Toulouse, France. | Specialty Telecommunications | Director/Board Member | |
FineHeart SA
FineHeart SA Pharmaceuticals: MajorHealth Technology FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France. | Pharmaceuticals: Major | Director/Board Member | |
EnobraQ SAS
EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member | |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer SAS (France)
Pfizer SAS (France) Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer SAS (France) is a French company that manufactures biopharmaceuticals. The company is based in Paris, France. The company was founded in 2000. Franck Le Breguero has been the CEO of the company since 2016. | Pharmaceuticals: Major | General Counsel | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Insead Business School | College/University | Masters Business Admin | |
Backbone SAS
Backbone SAS Medical SpecialtiesHealth Technology Backbone SAS is a venture capital and private equity firm. It specializes in investments in late venture companies, startups, buyouts, growth financing, leveraged buyouts, and buyins. The company was founded by Nazanine Sahami on March 25, 2015 and is headquartered in Le Bouscat, France. | Medical Specialties | Director/Board Member | |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Biotechnology | Director/Board Member | |
GeneSpire Srl
GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Chief Executive Officer | |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Swallis Medical SAS
Swallis Medical SAS Miscellaneous Commercial ServicesCommercial Services Swallis Medical SAS engages in the provision of diagnostic and monitoring solutions for problem of swallowing disorders. The company was founded by Linda Nicolini in 2019 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
Argobio SAS
Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research. | Miscellaneous Commercial Services | President | |
BAIO SAS
BAIO SAS Real Estate DevelopmentFinance BAIO SAS is a French company that offers rental of land and other real estate services. The company is based in Saint-Didier-au-Mont-d'Or, France. | Real Estate Development | President | |
Solina Group Holding SAS | Chairman | ||
IRDInov SAS
IRDInov SAS Financial ConglomeratesFinance IRDInov SAS functions as an investment holding French company. The private company is based in Paris, France. | Financial Conglomerates | Chairman | |
APSI 3D SAS | Director/Board Member | ||
Standing Ovation SAS
Standing Ovation SAS Food: Meat/Fish/DairyConsumer Non-Durables Part of UNIBEL SA, Standing Ovation SAS is a French company that specializes in animal-free dairy cheese. The company is based in Paris, France. Standing Ovation is focused on providing new solutions to environmental and ethical challenges. The company was founded in 2020 by Romain Chayot, Frédéric Pâques. Frédéric Pâques has been the CEO since 2020. Standing Ovation was acquired by Bel SA on November 15, 2022. | Food: Meat/Fish/Dairy | President | |
LID Technologies SAS
LID Technologies SAS Electrical ProductsProducer Manufacturing LDL Technology SAS designs, manufactures and develops wireless embedded electronic systems. Its technologies include tire pressure monitoring systems, vehicle immobilization, keyless entry and start system, and body control units. The company was founded by Dominique Luce and Philippe Lefaure on June 30, 2004 and is headquartered in Ramonville-Saint-Agne, France. | Electrical Products | Director/Board Member |
Estadísticas
Internacional
Francia | 42 |
Estados Unidos | 5 |
Canadá | 3 |
Italia | 3 |
Bélgica | 2 |
Sectorial
Health Technology | 18 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 5 |
Consumer Non-Durables | 4 |
Operativa
Director/Board Member | 85 |
Corporate Officer/Principal | 26 |
Chief Executive Officer | 22 |
Chairman | 17 |
Founder | 12 |
Las relaciones más conectadas
Insiders | |
---|---|
Jean-Michel Petit | 24 |
Johan Cardoen | 19 |
Thierry Laugel | 18 |
Marc Le Bozec | 16 |
Pierre Levi | 13 |
Alain Godard | 12 |
Alain Henri Roger Fanet | 11 |
Eric J. Rey | 11 |
Kevin Smith | 9 |
Simon Harnest | 7 |
Marie-Bleuenn Terrier | 6 |
Dirk Pollet | 6 |
Julia Berretta | 6 |
Eric Terré | 5 |
Michel Arbadji | 3 |
- Bolsa de valores
- Insiders
- Luc Mathis
- Conexiones Empresas